Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
The DOI matches its Crossref record; 299 of the 300 references it cites were found in a registry or an index.
Abstract
Bile acids (BAs) can regulate their own metabolism and transport as well as other key aspects of metabolic homeostasis via dedicated (nuclear and G protein-coupled) receptors. Disrupted BA transport and homeostasis results in the development of cholestatic disorders and contributes to a wide range of liver diseases, including nonalcoholic fatty liver disease and hepatocellular and cholangiocellular carcinoma. Furthermore, impaired BA homeostasis can also affect the intestine, contributing to the pathogenesis of irritable bowel syndrome, inflammatory bowel disease, and colorectal and oesophageal cancer. Here, we provide a summary of the role of BAs and their disrupted homeostasis in the development of gastrointestinal and hepatic disorders and present novel insights on how targeting BA pathways might contribute to novel treatment strategies for these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional microbial metabolites, such as conjugated bile acids, can activate the farnesoid X receptor, suppressing hepatic stellate cell activation and fibrogenic signaling, thereby ameliorating liver fibrosis105,106.”
From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [105]
In the citing paper
“Moreover, BAs have the potential to modulate the gut–brain axis by maintaining intestinal homeostasis, as TGR5 and FXR signaling are pivotal regulators of intestinal immune response and barrier function.365,376”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [376]
In the citing paper
“Peroxisome proliferator-activated receptors (PPARs), liver X receptors (LXRs), FXR and THR (particularly THR-β) are the most extensively studied receptors that are targets for therapy.20–22”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [20]
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Cited by
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D., & Patterson, A. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00805-x · Cited by 1,214
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
Self-citationThe gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737
Gut–liver axis: barriers and functional circuits
Pabst, O., Hornef, M. W., Schaap, F. G., Cerovic, V., Clavel, T., & Bruns, T. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00771-6 · Cited by 436
What defines a healthy gut microbiome?
Van Hul, M., Cani, P. D., Petitfils, C., De Vos, W. M., Tilg, H., & El-Omar, E. M. (2024) · Gut · doi:10.1136/gutjnl-2024-333378 · Cited by 369
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Wangchuk, P., Yeshi, K., & Loukas, A. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.08.003 · Cited by 333
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Tacke, F., Puengel, T., Loomba, R., & Friedman, S. L. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.038 · Cited by 321
Kuang, J., Wang, J., Li, Y., Li, M., Zhao, M., Ge, K., Zheng, D., Cheung, K. C. P., Liao, B., Wang, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.011 · Cited by 321
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Brevini, T., Maes, M., Webb, G. J., John, B. V., Fuchs, C. D., Buescher, G., Wang, L., Griffiths, C., Brown, M. L., Scott, W. E., et al. (2023) · Nature · doi:10.1038/s41586-022-05594-0 · Cited by 293
Self-citationBile acid metabolism and signalling in liver disease
Fuchs, C. D., Simbrunner, B., Baumgartner, M., Campbell, C., Reiberger, T., & Trauner, M. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.09.032 · Cited by 231
Self-citationLiver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Parola, M., & Pinzani, M. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 218
Tam, P. K. H., Wells, R. G., Tang, C. S.-M., Lui, V. C. H., Hukkinen, M., Luque, C. D., Coppi, P. D., Mack, C. L., Pakarinen, M. P., & Davenport, M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00533-x · Cited by 192
Another renaissance for bile acid gastrointestinal microbiology
Ridlon, J. M., & Gaskins, H. R. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00896-2 · Cited by 183
New Treatment Paradigms in Primary Biliary Cholangitis
Levy, C., Manns, M. P., & Hirschfield, G. M. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.02.005 · Cited by 166
Yu, Z., Li, D., & Sun, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114409 · Cited by 151
FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid
Wang, K., Zhang, Y., Wang, G., Hao, H., & Wang, H. (2024) · Medicinal Research Reviews · doi:10.1002/med.21991 · Cited by 117
The microbiota and the gut–liver axis in primary sclerosing cholangitis
Hov, J. R., & Karlsen, T. H. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00690-y · Cited by 141
Regulation of bile acids and their receptor FXR in metabolic diseases
Li, Y., Wang, L., Qing, Y., Luo, L., & Xiong, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1447878 · Cited by 125
The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity
He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 124
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 109
Host metabolism balances microbial regulation of bile acid signalling
Won, T. H., Arifuzzaman, M., Parkhurst, C. N., Miranda, I. C., Zhang, B., Hu, E., Kashyap, S., Letourneau, J., Jin, W., Fu, Y., et al. (2025) · Nature · doi:10.1038/s41586-024-08379-9 · Cited by 108
Microbiota-derived bile acids antagonize the host androgen receptor and drive anti-tumor immunity
Jin, W., Xiao, L., Jeong, M., Han, S.-J., Zhang, W., Yano, H., Shi, H., Arifuzzaman, M., Lyu, M., Wang, D., et al. (2025) · Cell · doi:10.1016/j.cell.2025.02.029 · Cited by 102
Song, L., Hou, Y., Xu, D., Dai, X., Luo, J., Liu, Y., Huang, Z., Yang, M., Chen, J., Hu, Y., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.008 · Cited by 96
Wu, L., Zhou, J., Zhou, A., Lei, Y., Tang, L., Hu, S., Wang, S., Xu, X., Chen, Q., Tu, D., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2390176 · Cited by 97
Recent advances on FXR-targeting therapeutics
Panzitt, K., Zollner, G., Marschall, H., & Wagner, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111678 · Cited by 94
Zhuang, Y., Ortega‐Ribera, M., Nagesh, P. T., Joshi, R., Huang, H., Wang, Y., Zivny, A., Mehta, J., Parikh, S. M., & Szabó, G. (2023) · Hepatology · doi:10.1097/hep.0000000000000611 · Cited by 94
Li, J., Guo, C., Liu, Y., Han, B., Lv, Z., Jiang, H., Li, S., & Zhang, Z. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.019 · Cited by 93
Angiocrine signaling in sinusoidal homeostasis and liver diseases
Gao, J., Lan, T., Kostallari, E., Guo, Y., Lai, E., Guillot, A., Ding, B., Tacke, F., Tang, C., & Shah, V. H. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.05.014 · Cited by 90
Bile acid-mediated signaling in cholestatic liver diseases
Zeng, J., Fan, J., & Zhou, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01035-1 · Cited by 84
Wang, M., Zhang, K.-H., Liu, F., Zhou, R., Zeng, Y., Chen, A., Yu, Y., Xia, Q., Zhu, C., & Lin, C. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155124 · Cited by 84
Zhou, S., You, H., Qiu, S., Yu, D., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113577 · Cited by 80
Primary sclerosing cholangitis
Manns, M. P., Bergquist, A. M., Karlsen, T. H., Levy, C., Muir, A. J., Ponsioen, C. Y., Trauner, M., Wong, G. L., & Younossi, Z. M. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00600-x · Cited by 81
Self-citationGut Microbial Metabolites on Host Immune Responses in Health and Disease
Yoon, J.-H., Do, J.-S., Velankanni, P., Lee, C., & Kwon, H. (2023) · Immune Network · doi:10.4110/in.2023.23.e6 · Cited by 71
The role of transketolase in human cancer progression and therapy
Hao, S., Meng, Q., Sun, H., Li, Y., Li, Y., Gu, L., Liu, B., Zhang, Y., Zhou, H., Xu, Z., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113607 · Cited by 70
Wang, Y., Li, Y., Lin, Y., Cao, C.-Y., Chen, D., Huang, X., Li, C., Xu, H., Lai, H., Chen, H., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02413-z · Cited by 70
Wang, C., Chu, Q., Dong, W., Wang, X., Zhao, W., Dai, X., Liu, W., Wang, B., Liu, T., Zhong, W., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101944 · Cited by 69
The Effect of Lithocholic Acid on the Gut-Liver Axis
Sheng, W., Ji, G., & Zhang, L. R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910493 · Cited by 69
Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
Ohtani, N., Kamiya, T., & Kawada, N. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000241 · Cited by 64
MetALD: Clinical aspects, pathophysiology and treatment
Gratacós‐Ginès, J., Ariño, S., Sancho‐Bru, P., Bataller, R. A., & Pose, E. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101250 · Cited by 62
Lin, X., Xia, L., Zhou, Y., Xie, J., Tuo, Q., Lin, L., & Liao, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094240 · Cited by 63
Li, H., Liu, C., Huang, S., Wang, X., Cao, M., Gu, T., Ou, X., Pan, S., Lin, Z., Wang, X., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2281350 · Cited by 62
Bile acid metabolism in type 2 diabetes mellitus
Sandoval, M. C., & Haeusler, R. A. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01067-8 · Cited by 60
Samy, A. M., Kandeil, M. A., Sabry, D., Abdel-Ghany, A. A., & Mahmoud, M. O. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30387 · Cited by 60
The gut microbiota-bile acid axis in cholestatic liver disease
Sun, D., Xie, C., Zhao, Y. M., Liao, J., Li, S., Zhang, Y., Wang, D., Hua, K., Gu, Y., Du, J., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00830-x · Cited by 61
Identification of gut microbial bile acid metabolic enzymes via an AI-assisted pipeline
Ding, Y., Luo, X., Guo, J., Xing, B., Lin, H., Ma, H., Wang, Y., Li, M., Ye, C., Yan, S. R., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.017 · Cited by 60
Aflatoxin B1 induces liver injury by disturbing gut microbiota-bile acid-FXR axis in mice
Liu, Y., Li, J., Kang, W., Liu, S., Liu, J., Shi, M., Wang, Y., Liu, X., Chen, X., & Huang, K. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113751 · Cited by 57
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 57
Seneff, S., & Kyriakopoulos, A. M. (2025) · Amino Acids · doi:10.1007/s00726-024-03440-3 · Cited by 56
Chen, Y., Shen, X., Ma, T., Yu, X., Kwok, L. Y., Li, Y., Sun, Z., Li, D., & Zhang, H. (2023) · mSystems · doi:10.1128/msystems.01300-22 · Cited by 55
Wu, Y., Zheng, Y., Wang, X., Tang, P., Guo, W., Ma, H., Zhang, A., Li, D., Xie, Y., Wang, C., et al. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x23500325 · Cited by 55
The Hylemon-Björkhem pathway of bile acid 7-dehydroxylation: history, biochemistry, and microbiology
Ridlon, J. M., Daniel, S. L., & Gaskins, H. R. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100392 · Cited by 54
Effect of gut flora mediated‐bile acid metabolism on intestinal immune microenvironment
Zhang, Y., Gao, X., Gao, S., Liu, Y., Wang, W., Feng, Y., Pei, L., Sun, Z., Liu, L., & Wang, C. (2023) · Immunology · doi:10.1111/imm.13672 · Cited by 53
Liu, A., Xu, C., Liu, Y., Sun, D., Jiang, L., Tang, L., Zhu, P., Chen, S., Liu, W., Wang, X., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17362 · Cited by 51
Gastric intestinal metaplasia: progress and remaining challenges
Tong, Q.-Y., Pang, M.-J., Hu, X.-H., Huang, X., Sun, J., Wang, X., Burclaff, J., Mills, J. C., Wang, Z.-N., & Miao, Z. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-023-02073-9 · Cited by 50
Update on the development of TGR5 agonists for human diseases
Jin, W., Zheng, M., Chen, Y., & Xiong, H. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116462 · Cited by 50
Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 46
Cholesterol in the CNS: functions, recycling and remyelination
Wuerch, E. C., & Yong, V. W. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03490-8 · Cited by 47
Wang, S., Yin, J., Liu, Z., Liu, X., Tian, G., Xin, X., Qin, Y., & Feng, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123211 · Cited by 46
Advances in gut-lung axis research: clinical perspectives on pneumonia prevention and treatment
Ye, F., Li, L., Wang, J., & Hongfeng, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1576141 · Cited by 44
Luo, X., Wang, K., & Jiang, C. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.04.020 · Cited by 45
Microbiota-derived bile acid metabolic enzymes and their impacts on host health
Ma, H., Wang, K., & Jiang, C. (2025) · Cell Insight · doi:10.1016/j.cellin.2025.100265 · Cited by 46
Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
Shi, Q., Yuan, X., Zeng, Y., Wang, J., Zhang, Y., Chen, X., & Li, L. (2023) · Nutrients · doi:10.3390/nu15102411 · Cited by 43
Wu, K., Liu, Y., Xia, J. L., Liu, J., Wang, K., Liang, H., Xu, F., Liu, D., Nie, D., Tang, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202304408 · Cited by 41
Dixon, E. D., Claudel, T., Nardo, A. D., Riva, A., Fuchs, C. D., Mlitz, V., Busslinger, G. A., Scharnagl, H., Stojaković, T., Séneca, J., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.09.037 · Cited by 41
Self-citationArabinoxylan Alleviates Obesity by Regulating Gut Microbiota and Bile Acid Metabolism
Lin, J., Liu, H., Sun, Y., Zou, J., Nie, Q., & Nie, S. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c06392 · Cited by 41
Chen, F., & Gong, L. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1689026 · Cited by 41
Pediatric Cholestatic Diseases: Common and Unique Pathogenic Mechanisms
Sutton, H., Karpen, S. J., & Kamath, B. M. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-025623 · Cited by 39
Jiang, K., Bai, Y., Hou, R., Chen, G., Liu, L., Ciftci, O. N., Farag, M. A., & Liu, L. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.142932 · Cited by 39
Abdel-Rasol, M. A., & El-Sayed, W. M. (2025) · European journal of medical research · doi:10.1186/s40001-025-03073-6 · Cited by 39
Zhang, L., Shi, J., Shen, Q., Fu, Y., Qi, S., Wu, J., Chen, J., Zhang, H., Mu, Y., Chen, G., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116833 · Cited by 37
Zhao, R., Ji, Y., Chen, X., Ma, G., Yao, H., Li, J., Hu, Q., & Zhao, L. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127308 · Cited by 37
Li, Z., Zhang, R., Mu, H., Zhang, W., Zeng, J., Li, H., Wang, S., Zhao, X., Chen, W., Dong, J., et al. (2022) · Nutrients · doi:10.3390/nu14235065 · Cited by 37
Liu, Y., Liu, T., Zhao, X. M., & Gao, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04509-6 · Cited by 36
Gao, Y., Lin, J., Ye, C., Guo, S., & Jiang, C. (2023) · Liver Research · doi:10.1016/j.livres.2023.09.002 · Cited by 36
Li, Z., Li, C., Lin, F., Yan, L., Wu, H., Zhou, H., Guo, Q., Lin, B., Xie, B., Xu, Y., et al. (2024) · Poultry Science · doi:10.1016/j.psj.2024.103647 · Cited by 35
Zhang, T., Hasegawa, Y., & Waldor, M. K. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01862-z · Cited by 35
Targetome-guided combination drug discovery as next-generation therapeutics
Liu, P., Huang, F., Zheng, X., & Hao, H. (2025) · Targetome · doi:10.48130/targetome-0025-0002 · Cited by 36
Wang, X., Lv, Y., Qiang, X., Liang, S., Li, R., Zhan, J., & Liu, J. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.175312 · Cited by 34
Bile Acids and Biliary Fibrosis
Aseem, S. O., Hylemon, P. B., & Zhou, H. (2023) · Cells · doi:10.3390/cells12050792 · Cited by 34
Sun, X., Chen, Z., Yu, L., Zeng, W., Sun, B., Fan, H., & Bai, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205323 · Cited by 33
Wang, Y., Chen, X., Huws, S., Xu, G., Li, J., Ren, J., Xu, J., Guan, L. L., Yao, J., & Wu, S. (2024) · Microbiome · doi:10.1186/s40168-024-01964-0 · Cited by 33
Stimulation of the farnesoid X receptor promotes M2 macrophage polarization
Jaroonwitchawan, T., Arimochi, H., Sasaki, Y., Ishifune, C., Kondo, H., Otsuka, K., Tsukumo, S., & Yasutomo, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1065790 · Cited by 33
The role of the gut microbiome in disorders of gut–brain interaction
Gawey, B. J., Mars, R. A. T., & Kashyap, P. (2024) · FEBS Journal · doi:10.1111/febs.17200 · Cited by 32
Sun, Y., Men, Q., Ren, X., Yan, C., Song, S., & Ai, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136930 · Cited by 32
Bile acid signaling in MASLD: From pathogenesis to therapeutic applications
Simbrunner, B., Paternostro, R., Reiberger, T., & Trauner, M. (2025) · Hepatology · doi:10.1097/hep.0000000000001539 · Cited by 33
Self-citationLuo, W., Guo, S., Zhou, Y., Zhu, J., Zhao, J., Wang, M., Sang, L.-X., Wang, B., & Chang, B. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5407 · Cited by 32
Chen, Q., Yin, Q., Xie, Q., Liu, S., Guo, Z., & Li, B. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.135413 · Cited by 32
Tang, R., Liu, R., Zha, H., Cheng, Y., Ling, Z., & Li, L. (2023) · Engineering in Life Sciences · doi:10.1002/elsc.202300016 · Cited by 32
Microbiota-dependent metabolites – New engine for T cell warriors
Tang, Y., Fu, A., Wang, L., & Ge, Q. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2523815 · Cited by 31
Luo, D., Chen, X., Dai, Y., Kuang, F. L., Kang, M., Li, B., & Su, S. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000332 · Cited by 31
Gut–Liver Axis as a Therapeutic Target for Drug-Induced Liver Injury
Tao, W., Fan, Q., & Wei, J. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46020078 · Cited by 30
Guo, Z., He, K., Pang, K., Yang, D., Lyu, C., Xu, H., & Wu, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084321 · Cited by 31
Dong, X., Sun, F., Secaira-Morocho, H., Hui, A., Wang, K., Cai, C., Udgata, S., Low, B., Wei, S., Chen, X., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317596121 · Cited by 30
Irradiation-Induced Intestinal Injury is Associated With Disorders of Bile Acids Metabolism
Guo, L. Q., Da, F., Gao, Q., Miao, X., Guo, J., Zhang, W., Li, J., Wang, J., & Liu, J. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.08.007 · Cited by 30
Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
Long, X.-Q., Liu, M., Liu, Z.-H., Xia, L.-Z., Lu, S.-P., Xu, X.-P., & Wu, M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i27.4252 · Cited by 30
The Pan-liver Network Theory: From Traditional Chinese Medicine to Western Medicine
Zhang, Y., & Fang, X.-M. (2023) · The Chinese Journal of Physiology · doi:10.4103/cjop.cjop-d-22-00131 · Cited by 30
Simbrunner, B., Hofer, B., Schwabl, P., Zinober, K., Petrenko, O., Fuchs, C. D., Semmler, G., Marculescu, R., Mandorfer, M., Datz, C., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10636-4 · Cited by 29
Self-citationEmerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
Xun, Z., Yao, X., & Ou, Q. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01026-9 · Cited by 29
Microbially conjugated bile salts found in human bile activate the bile salt receptors TGR5 and FXR
Ay, Ü., Leníček, M., Haider, R. S., Claßen, A., van Eijk, H. M. H., Koelfat, K. V. K., van der Kroft, G., Neumann, U. P., Hoffmann, C., Bolm, C., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000383 · Cited by 29
Metadata
- Authors
- Fuchs, C. D., & Trauner, M.
- Affiliations
- Medical University of Vienna (AT)
- Corresponding author
- Trauner, Michael
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2022-02-14
- Volume
- 19
- Issue
- 7
- Pages
- 432-450
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4212954224
- Cited by
- 490
- References
- 300
- Citations by year
- 2026: 134 · 2025: 145 · 2024: 111 · 2023: 77 · 2022: 23
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- bile acids, bile acid receptors, nuclear receptors, G protein-coupled receptors, bile acid homeostasis, bile acid transport, cholestasis, non-alcoholic fatty liver disease, hepatocellular carcinoma, cholangiocarcinoma, irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, esophageal cancer
- MeSH terms
- Bile Acids and Salts, Cholestasis, Homeostasis, Humans, Liver, Receptors, G-Protein-Coupled, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.